Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 1,818 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Type 1 Diabetes Mellitus
Interventions: Donislecel (allogeneic islets of Langerhans for transplant); Biological
Lead sponsor: CellTrans Inc.; Industry
Eligibility: 18 Years to 75 Years
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Depression, Anxiety, Satisfaction, Well-being
Interventions: Comprehensive Well-Being Intervention; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Geographic Atrophy, Stargardt Disease, RPE-mediated Maculopathy, Age Related Macular Degeneration
Interventions: Injection; Biological
Lead sponsor: Cellio Therapeutics Inc; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Beverly Hills, California • Palo Alto, California • Sacramento, California

Conditions: Obesity
Interventions: Peptamen Intense VHP, Nestlé Health Science, Switzerland; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stress Disorders, Post-Traumatic, Depression, Antisocial Personality Disorder, Anxiety, Aggressive Behavior
Interventions: RRF4H Combination Intervention; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 14 Years to 17 Years
Enrollment: 308 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Otitis Media, Middle Ear Effusion
Interventions: Insertion of tympanostomy tubes; Procedure
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 0 Years to 61 Days
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: COVID-19 Vaccination
Interventions: COVID-19 Video, COVID-19 Words, COVID-19 Poster; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 1,064 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: State College, Pennsylvania

Conditions: Obesity, Overweight
Interventions: Podcasting + mobile media; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 60 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran
Interventions: Psilocybin (Usona Institute); Drug
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 22 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Epilepsy, Seizure Disorder
Interventions: PatientsLikeMe.com; Behavioral
Lead sponsor: Northern California Institute of Research and Education; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: HIV
Interventions: HIV knowledge Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 558 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Presbyopia
Interventions: AGN-241622, Vehicle; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 40 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 10
States / cities: Inglewood, California • Los Angeles, California • Mission Hills, California + 7 more

Conditions: Urinary Tract Infections
Interventions: Expanded Urinary Culture, Standard Urine Culture (SUC); Diagnostic Test
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: ADHD
Interventions: methylphenidate, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 7 Years to 13 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Age-Related Macular Degeneration
Interventions: ASP7317, tacrolimus, trimethoprim-sulfamethoxazole, Acyclovir, Nystatin; Drug
Lead sponsor: Astellas Institute for Regenerative Medicine; Industry
Eligibility: 50 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 20
States / cities: Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 16 more

Conditions: Premature Birth, Counseling, Decision Making, Prenatal Care, Infant, Premature, Resuscitation
Interventions: Multimedia Information, Printed Handout; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Portal Hypertension, Cirrhosis
Interventions: HVPG, Indocyanine Green Retention test, Liver stiffness measurement, Spleen stiffness measurement; Procedure · Drug · Device
Lead sponsor: VA Connecticut Healthcare System; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: New Haven, Connecticut • West Haven, Connecticut

Conditions: Eczema/Atopic Dermatitis, Cancer
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Idiopathic Short Stature
Interventions: Vosoritide Injection, Human Growth Hormone, Placebo; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 3 Years to 11 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2036
U.S. locations: 35
States / cities: California City, California • Los Angeles, California • Oakland, California + 28 more

Conditions: Health Care Utilization
Interventions: Peer Leader Model; Other
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 100 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Breast Cancer
Interventions: Envision the Rhythms of Life Program, Envision the Rhythms of Life Program/Distance; Behavioral
Lead sponsor: Mind Matters Research LLC; Other
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Open-Angle Glaucoma, Ocular Hypertension
Interventions: DE-104 ophthalmic solution, low concentration, DE-104 ophthalmic solution, medium concentration, DE-104 ophthalmic solution, high concentration, Placebo, 0.005% latanoprost; Drug
Lead sponsor: Santen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 14
States / cities: Artesia, California • Los Angeles, California • Torrance, California + 9 more

Conditions: ALS (Amyotrophic Lateral Sclerosis)
Interventions: Lunasin Regimen, Historical control; Drug · Other
Lead sponsor: Richard Bedlack, M.D., Ph.D.; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Heart Failure
Interventions: Main cohort (Cohort A): Ponsegromab low dose, Main cohort (Cohort A): Ponsegromab medium dose, Main cohort (Cohort A): ponsegromab high dose, Main cohort (Cohort A): Matched placebo, Open-label, PK Cohort (Cohort B): ponsegromab low dose, Open-label, PK Cohort (Cohort B): ponsegromab medium dose, Open-label, PK Cohort (Cohort B): ponsegromab high dose, Optional Cohort C: Ponsegromab low dose, Optional Cohort C: Matched placebo, Optional Cohort D: Ponsegromab high dose, Optional Cohort D: Matched placebo; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 455 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 22
States / cities: Fairhope, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 13 more

Search by objective public record fields.

Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

A Tailored and Digital Approach to Address Equity and Support Well-being for Healthcare Workers in the Era of COVID

Phase 1 Study of C.001 in Retinal Degeneration

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

Resettled Refugee Families for Healing

Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11

Influence of Vaccine Message Medium on Intentions to Vaccinate in College Students

Pounds Off Digitally (POD): The Use of Podcasting and Mobile Media to Promote Weight Loss

Psilocybin to Treat Depression in Spinal Cord Injury

Policy on Optimal Epilepsy Management

HOPE (Harnessing Online Peer Education): Using Online Social Networks for HIV Prevention and Testing

Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

Expanded Quantitative Urinary Culture (EQUC) vs Standard Culture (SUC) Techniques in the Clinical Care

Stimulant Drug Treatment of Attention-Deficit Hyperactivity Disorder (AD/HD), Inattentive Type

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Counseling for Prematurity Using a Multimedia Education Tool

Surrogate Markers of Portal Pressure

Patient Forward Access to Clinical and Technological Research: Genetic Influences on Cancer and Atopic Dermatitis

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

Increasing Teen Access to Sexual and Mental Health Care

Multi-Media Imagery Program for Breast Cancer Patients (Phase II)

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

ALS Reversals - Lunasin Regimen

A Study of Ponsegromab in People With Heart Failure